The Massachusetts Hepatitis C Testing Cascade, 2014-2016
Open Access
- 1 January 2019
- journal article
- research article
- Published by SAGE Publications in Microbiology Insights
- Vol. 12
Abstract
Objectives: To characterize hepatitis C testing in Massachusetts and guide stakeholders in addressing the needs of people living with hepatitis C. Methods: All persons with a positive laboratory report for anti-hepatitis C virus (HCV) antibody, between 2014 and 2016, were included in the testing cascade. Outcomes were HCV tests received after a positive anti-HCV antibody test: nucleic acid test or genotype test. Logistic regression analyses were performed to determine factors associated with progression through the HCV testing cascade. Results: Among those reported anti-HCV antibody positive, a total of 13 194 (61%) cases had a subsequent RNA-based test, and 79% (10 374/13 194) were confirmed with current, active HCV infection. For confirmed HCV cases, 44% (4557/10 374) had a genotype identified. The median time from an antibody-positive test to a RNA-based test was 29 days (interquartile range [IQR] = 7-151). Differences in moving through the testing cascade were observed by birth cohort and race/ethnicity. Conclusions: Improved surveillance capture of demographic information is needed to help public health agencies ensure equity in HCV diagnosis and linkage to care.Keywords
This publication has 12 references indexed in Scilit:
- Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort StudyOpen Forum Infectious Diseases, 2018
- Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United StatesClinical Infectious Diseases, 2018
- A Public Health Approach to Hepatitis C in an Urban SettingAmerican Journal of Public Health, 2017
- Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of InsuranceClinical Gastroenterology and Hepatology, 2016
- Rising Mortality Associated With Hepatitis C Virus in the United States, 2003–2013Clinical Infectious Diseases, 2016
- Hepatitis C Surveillance Markers Study: A Validation of Genotype as a Laboratory Proxy for Linkage to CareOpen Forum Infectious Diseases, 2015
- Infectious Disease Surveillance in the 21st Century: An Integrated Web-Based Surveillance and Case Management SystemPublic Health Reports®, 2014
- Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians2013
- Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individualsAntiviral Therapy, 2012
- Massachusetts Health Care Reform: A Look At The IssuesHealth Affairs, 2006